Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acura Pharmaceuticals Inc (NASDAQ:ACUR)

0.60
Delayed Data
As of 3:42pm ET
 0.00 / 0.00%
Today’s Change
0.51
Today|||52-Week Range
3.52
-21.72%
Year-to-Date

Today’s Trading

Previous close0.60
Today’s open0.60
Day’s range0.58 - 0.62
Volume91,548
Average volume (3 months)76,858
Market cap$7.1M
Dividend yield--
Data as of 3:42pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)+65.93%
Earnings growth (this year)-121.74%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,043.41%
P/E ratioNM
Price/Sales3.14
Price/Book0.90

Competitors

 Today’s
change
Today’s
% change
CBIOCatalyst Biosciences...-0.02-2.58%
BSPMBiostar Pharmaceutic...-0.06-2.13%
OPXAOpexa Therapeutics I...+0.01+0.55%
SSKNSTRATA Skin Sciences...+0.01+1.00%
Data as of 3:58pm ET, 01/23/2017

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$8.6M
Annual profit (last year)-$5.0M
Net profit margin-58.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Robert B. Jones
CFO, Secretary, SVP &
Head-Investor Relations
Peter A. Clemens
Corporate headquarters
Palatine, Illinois

Forecasts


Search for Jobs